Oregon Public Employees Retirement Fund Boosts Stock Position in Zoetis Inc. $ZTS

Oregon Public Employees Retirement Fund raised its stake in Zoetis Inc. (NYSE:ZTS) by 32.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 50,693 shares of the company’s stock after acquiring an additional 12,279 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Zoetis were worth $7,417,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Nova Wealth Management Inc. acquired a new stake in shares of Zoetis during the first quarter worth $25,000. Halbert Hargrove Global Advisors LLC lifted its stake in shares of Zoetis by 496.6% in the 3rd quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after acquiring an additional 144 shares during the period. REAP Financial Group LLC lifted its stake in shares of Zoetis by 201.5% in the 2nd quarter. REAP Financial Group LLC now owns 196 shares of the company’s stock worth $31,000 after acquiring an additional 131 shares during the period. NewSquare Capital LLC boosted its holdings in shares of Zoetis by 69.1% in the second quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after acquiring an additional 85 shares in the last quarter. Finally, 1248 Management LLC acquired a new position in shares of Zoetis during the first quarter worth about $35,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ZTS has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. reduced their price objective on shares of Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Bank of America downgraded Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 target price for the company. in a research note on Monday, December 15th. The Goldman Sachs Group raised Zoetis to a “buy” rating in a report on Monday, December 15th. KeyCorp began coverage on Zoetis in a report on Thursday, November 20th. They set a “sector weight” rating on the stock. Finally, Morgan Stanley set a $160.00 price objective on Zoetis in a research report on Thursday, December 18th. Six research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $160.18.

Zoetis Stock Performance

NYSE ZTS opened at $127.10 on Friday. Zoetis Inc. has a 1-year low of $115.25 and a 1-year high of $177.40. The company has a market capitalization of $56.01 billion, a P/E ratio of 21.40, a PEG ratio of 2.58 and a beta of 0.97. The business has a 50 day moving average price of $123.29 and a 200 day moving average price of $140.72. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.42 billion. During the same period in the previous year, the business earned $1.58 earnings per share. Zoetis’s quarterly revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be given a $0.53 dividend. This is a boost from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, January 20th. Zoetis’s dividend payout ratio (DPR) is currently 33.67%.

Zoetis Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.